Cargando…
Can artificial intelligence identify effective COVID‐19 therapies?
In this issue of EMBO Molecular Medicine, Stebbing et al (2020b) validate an artificial intelligence‐assisted prediction that a drug used to treat rheumatoid arthritis could be a potent weapon against COVID‐19. Using liver organoids infected with SARS‐CoV‐2, they confirm dual antiviral and anti‐infl...
Autores principales: | Schultz, Michael B, Vera, Daniel, Sinclair, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361072/ https://www.ncbi.nlm.nih.gov/pubmed/32569446 http://dx.doi.org/10.15252/emmm.202012817 |
Ejemplares similares
-
Intelligent metasurfaces can recognize objects
por: Ren, Mengxin, et al.
Publicado: (2022) -
Artificial Intelligence and brain
por: Shapshak, Paul
Publicado: (2018) -
Intelligent metasurfaces: digitalized, programmable, and intelligent platforms
por: Zhang, Shuang
Publicado: (2022) -
Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19
por: Banerjee, Rahul, et al.
Publicado: (2020) -
COVID-19 can be called a treatable disease only after we have antivirals
por: Zhang, Xueyang, et al.
Publicado: (2022)